Highlights from Session 1 of the Heart Failure Summit 2023 – with Prof. Andrew Sindone, Prof. John Atherton, and Dr Anita Sharma
To access this content, please register or log in.
The guidelines evolution and remaining problems: nonadherence to guidelines and undertreatment.
Current Heart Failure epidemiology and its impact on quality of life.
Latest Australian Consensus Statement with new recommendations. Supplementary elements of HF management (the use of diuretics, multidisciplinary approach in titration and exercise training).
ARNI (angiotensin receptor neprilysin inhibitor) adding NEPi, and (SGLT2i) sodium–glucose cotransporter 2 inhibitors
Overview of the current available options and their efficacy.